tiprankstipranks
Alamar Biosciences, Inc. (ALMR)
NASDAQ:ALMR
US Market
Want to see ALMR full AI Analyst Report?

Alamar Biosciences, Inc. (ALMR) Price & Analysis

11 Followers

ALMR Stock Chart & Stats

$26.69
$1.85(7.45%)
--

ALMR FAQ

What was Alamar Biosciences, Inc.’s price range in the past 12 months?
Alamar Biosciences, Inc. lowest stock price was $21.50 and its highest was $27.00 in the past 12 months.
    What is Alamar Biosciences, Inc.’s market cap?
    Currently, no data Available
    When is Alamar Biosciences, Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Alamar Biosciences, Inc.’s earnings last quarter?
    Currently, no data Available
    Is Alamar Biosciences, Inc. overvalued?
    According to Wall Street analysts Alamar Biosciences, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
      Does Alamar Biosciences, Inc. pay dividends?
      Alamar Biosciences, Inc. does not currently pay dividends.
      What is Alamar Biosciences, Inc.’s EPS estimate?
      Alamar Biosciences, Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Alamar Biosciences, Inc. have?
      Alamar Biosciences, Inc. has 67,163,280 shares outstanding.
        What happened to Alamar Biosciences, Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Alamar Biosciences, Inc.?
        Currently, no hedge funds are holding shares in ALMR
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          Alamar Biosciences, Inc.

          Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.

          Ownership Overview

          11.01%88.10%
          11.01% Insiders
          ― Other Institutional Investors
          88.10% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks